Pauliková I
Comenius University in Bratislava
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Pauliková I.
FEBS Journal | 2006
Anna Hrabovska; Jean‐Claude Debouzy; Marie-Thérèse Froment; Ferdinand Devínsky; Pauliková I; Patrick Masson
The purpose of this work was to study the catalytic properties of rat butyrylcholinesterase with benzoylcholine (BzCh) and N‐alkyl derivatives of BzCh (BCHn) as substrates. Complex hysteretic behaviour was observed in the approach to steady‐state kinetics for each ester. Hysteresis consisted of a long lag phase with damped oscillation. The presence of a long lag phase, with no oscillations, in substrate hydrolysis by rat butyrylcholinesterase was also observed with N‐methylindoxyl acetate as substrate. Hysteretic behaviour was explained by the existence of two interconvertible butyrylcholinesterase forms in slow equilibrium, while just one of them is catalytically active. The damped oscillations were explained by the existence of different substrate conformational states and/or aggregates (micelles) in slow equilibrium. Different substrate conformational states were confirmed by 1H‐NMR. The Km values for substrates decreased as the length of the alkyl chain increased. High affinity of the enzyme for the longest alkyl chain length substrates was explained by multiple hydrophobic interactions of the alkyl chain with amino acid residues lining the active site gorge. Molecular modelling studies supported this interpretation; docking energy decreased as the length of the alkyl chain increased. The long‐chain substrates had reduced kcat values. Docking studies showed that long‐chain substrates were not optimally oriented in the active site for catalysis, thus explaining the slow rate of hydrolysis. The hydrolytic rate of BCH12 and longer alkyl chain esters vs. substrate concentration showed a premature plateau far below Vmax. This was due to the loss of substrate availability. The best substrates for rat butyrylcholinesterase were short alkyl homologues, BzCh – BCH4.
Biologia | 2006
Pauliková I; Anna Hrabovska; Helia O; Ferdinand Devínsky
Butyrylcholinesterase (BuChE) occurs in a multiple molecular forms whose catalytic activity depends on tissue distribution and species. The hypothesis led us to the study of BuChE catalytic properties focused on the inter-tissue and inter-species level with benzoylcholine and N-alkyl derivates of benzoylcholine (BCHn) as substrates. These compounds are soft disinfectants easily biodegradable to biologically inactive hydrolytic products, substituted choline and benzoic acid. Different sources of BuChE were used: rabbit and rat liver microsomal fraction (membrane-anchored enzyme) and serum (soluble form). Hydrolytic activity of both these BuChE forms was compared to rat recombinant BuChE (rBuChE). Hydrolytic product (benzoic acid) formation was recorded as function of time, and hydrolytic rate was determined. Tissue distribution of BuChE plays an important role in hydrolysis of BCHn. High BuChE activity was observed in a serum of both studied species rat and rabbit and was significantly dependent on a structure of substrates. Activity of soluble serum forms was the same as that for the rBuChE. Significant change of BuChE activity was recorded on the inter-species level in the microsomal fractions. It is because the rabbit microsomal BuChE activity had absolutely different course for all substrates as compared to rat microsomes. Inhibitory studies of BCHn enzymatic hydrolysis of all BuChE forms were performed to determine the level of BuChE participation in BCHn hydrolysis. It can be concluded that short-chain BCHn substrates are exclusively hydrolyzed by BuChE from all studied sources except for the rabbit liver microsomal fraction. Rabbit seems to have different enzymes involved in the hydrolysis of all studied BCHn compounds.
Clinical & Developmental Immunology | 2016
Ľudmila Pašková; Viera Kuncirova; Silvester Ponist; Danica Mihalova; Radomír Nosáľ; Juraj Harmatha; Iveta Hrádková; Tomáš Čavojský; F. Bilka; Katarína Šišková; Pauliková I; Lýdia Bezáková; Katarína Bauerová
Rheumatoid arthritis (RA) is a chronic inflammatory disease, leading to progressive destruction of joints and extra-articular tissues, including organs such as liver and spleen. The purpose of this study was to compare the effects of a potential immunomodulator, natural polyphenol N-feruloylserotonin (N-f-5HT), with methotrexate (MTX), the standard in RA therapy, in the chronic phase of adjuvant-induced arthritis (AA) in male Lewis rats. The experiment included healthy controls (CO), arthritic animals (AA), AA given N-f-5HT (AA-N-f-5HT), and AA given MTX (AA-MTX). N-f-5HT did not affect the body weight change and clinical parameters until the 14th experimental day. Its positive effect was rising during the 28-day experiment, indicating a delayed onset of N-f-5HT action. Administration of either N-f-5HT or MTX caused reduction of inflammation measured as the level of CRP in plasma and the activity of LOX in the liver. mRNA transcription of TNF-α and iNOS in the liver was significantly attenuated in both MTX and N-f-5HT treated groups of arthritic rats. Interestingly, in contrast to MTX, N-f-5HT significantly lowered the level of IL-1β in plasma and IL-1β mRNA expression in the liver and spleen of arthritic rats. This speaks for future investigations of N-f-5HT as an agent in the treatment of RA in combination therapy with MTX.
Acta Facultatis Pharmaceuticae Universitatis Comenianae | 2013
Veronika Kováčiková; Marek Obložinský; Renáta Kollárová; Lýdia Bezáková; Katarína Šišková; Pauliková I
Animal lipoxygenases (EC 1.13.11.12, LOX) convert arachidonic acid to biological active compounds known as eicosanoids. Proinflammatory eicosanoids - leukotrienes are involved in progression of atherosclerosis. Our attention was focused on a connection between activity of LOX and primary hypertriacylglycerolaemia, untreated or treated with fenofibrate. Our results show that LOX activity in the cytoplasm derived from liver of hypertriacylglycerolaemic rats is significantly increased (pH 7,2; relative to the control group), which may be one reason for more rapid atherosclerosis progression in lipid metabolism disorders. The highest LOX activity in microsomes was showed in groups of rats treated with fenofibrate. It appears that fibrates indirectly promote association of LOXs to membranes. In fat fraction no significant effect of hypertriacylglycerolaemia on the activity of lipoxygenase was found. Using gel electrophoresis significantly different spectrum of proteins was discovered in the control samples and samples of hypertriacylglycerolaemic rats. It appears that in condition of lipid metabolism imbalance formation of proteins with low molecular weight (and possibly also expression of LOX) is elevated.
General Physiology and Biophysics | 2008
Kuzelová M; Adriana Adameova; Zuzana Sumbalova; Pauliková I; Harcárová A; Svec P; Kucharská J
Die Pharmazie | 2012
Katarína Šišková; F. Bilka; Adriana Adameova; Balazová A; Mydla M; Pauliková I
Collection of Czechoslovak Chemical Communications | 1998
Eva Olaszová; Pauliková I; Helia O; Emil Švajdlenka; Ferdinand Devínský; Ivan Lacko
Die Pharmazie | 1995
Helia O; Pauliková I; Emil Švajdlenka; Ferdinand Devínsky; Ivan Lacko; Olaszová E
Chemical Papers | 2017
Gilda Liskayová; Lukáš Hubčík; Katarína Šišková; Pauliková I; Dominika Galliková; Ferdinand Devínsky; Sérgio S. Funari; Daniela Uhríková
Physiological Research | 2016
Katarína Šišková; Martina Dubničková; Pašková Ľ; Rajdl D; Zdeňka Ďuračková; Jana Muchová; Pauliková I; Racek J